318 Olaparib plus pembrolizumab in patients with previously treated advanced solid tumors with homologous recombination repair mutation and/or homologous recombination repair deficiency: KEYLYNK-007

318 Olaparib plus pembrolizumab in patients with previously treated advanced solid tumors with homologous recombination repair mutation and/or homologous recombination repair deficiency: KEYLYNK-007

Bibliographic Details
Main Authors: Andrew E Hendifar, Douglas A Levine, Ronnie Shapira-Frommer, Sanatan Saraf, Michele Maio, Timothy A Yap, Mallika Dhawan, Taofeek K Owonikoko, Miguel Quintela-Fandino, Ping Qiu, Fan Jin, Alexander Gozman
Format: Article
Language:English
Published: BMJ Publishing Group 2020-11-01
Series:Journal for ImmunoTherapy of Cancer

Similar Items